SDRL | Seadrill 2021 Ltd

CUSIP: G7997W102

1 Funds Holding

2.0M Total Shares

$74M Total Value

$48.38
Price

$3.0B

Market Cap

1612.7

P/E Ratio

14.1

Forward P/E

$0.03

EPS (TTM)

—

Dividend Yield

$337M

Cash

$631M

Total Debt

63M

Shares Out

$28.10

$55.47

52-Week Range

Fund / Manager Click to search	Shares	Value	% of Portfolio	Cost Basis	Est. Return
Patient Capital Management\|Samantha McLemore	2.0M	$74M	2.42%	$38.26	+26.44%

Quarter:

Fund / Manager Click to search	Action	Change	Shares After	Value	Price
2026-Q2
Patient Capital Management	SELL	-9.3%	2.0M	$74M	$47.52
2026-Q1
Patient Capital Management	BUY	+4.8%	2.2M	$98M	$42.25
2025-Q4
Patient Capital Management	SELL	-7.9%	2.1M	$71M	$30.97
2025-Q3
Patient Capital Management	BUY	+0.0%	2.2M	$67M	$30.50
2025-Q2
Patient Capital Management	BUY	+13.0%	2.2M	$59M	$23.79
Third Point LLC	SELL	EXIT	—	—	$23.79
2025-Q1
Patient Capital Management	BUY	+17.6%	2.0M	$49M	$31.22
2024-Q4
Patient Capital Management	BUY	+63.5%	1.7M	$65M	$39.03
Third Point LLC	BUY	NEW	1.0M	$40M	$39.03
2024-Q3
Patient Capital Management	BUY	+13.0%	1.0M	$41M	$44.57
2024-Q2
Patient Capital Management	BUY	+0.8%	907.6K	$47M	$50.74
2024-Q1
Patient Capital Management	BUY	+35.9%	900.3K	$45M	$44.72
2023-Q4
Patient Capital Management	BUY	NEW	662.6K	$31M	$42.05

No Insider Transactions

No Form 4 filings found for this stock in the last 2 years.